Pay in 4 interest-free payments of $5.79 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
-Syn, -Synuclein
In addition to delivering meaningful weight loss, mGIPR-Ab/GLP-1 also provides metabolic benefits in downstream peripheral tissues
If you are participating in a clinical trial and experience a suspected side effect, you should report it via the MHRA Yellow Card Scheme at yellowcard.mhra.gov.uk or through the Yellow Card app
Key Regions and Countries North America US Canada Europe Germany France The UK Spain Italy Russia Netherland Rest of Europe Asia Pacific China Japan South Korea India Australia New Zealand Singapore Thailand Vietnam Rest of APAC Latin America Brazil Mexico Rest of Latin America Middle East & Africa South Africa Saudi Arabia UAE Rest of MEA Key Players Analysis The anti-obesity drugs market is currently dominated by two pharmaceutical giants: Novo Nordisk and Eli Lilly
Benefits of IGF-1 LR3 6.1 Muscle Growth and Repair Accelerates regeneration of damaged muscle fibers Enhances hypertrophy when paired with resistance training Supports recovery from injury 6.2 Fat Metabolism Increases lean body mass while reducing fat mass Promotes greater caloric expenditure at rest 6.3 Connective Tissue and Joint Health Stimulates collagen synthesis in tendons and ligaments Supports rehabilitation from overuse injuries 6.4 Bone Density Support Promotes osteoblast activity and bone remodeling May help counteract osteoporosis risk 6.5 Anti-Aging Potential Supports maintenance of muscle mass with age Enhances repair mechanisms in multiple tissues 7
When combined with insulin or other medicines that lower blood glucose levels, the patient is at an increased risk of low blood sugar
US$ 20.60
US$ 26.93
US$ 21.33
US$ 21.24
US$ 29.00
